Humira Sales Lift AbbVie Profit

Related Link: 

AbbVie Inc. said its second-quarter earnings rose as strong global sales of the drug maker's rheumatoid-arthritis drug Humira continued to boost results.

Tencent Private Bank Plan Gets Approval

Related Link: 

China's banking regulator approved the establishment of three private banks, with one green light going to Chinese Internet company Tencent Holdings.

Statoil Took US Write-down, Says CEO

Related Link: 

Statoil's Chief Executive said the company had taken a write down on its U.S. onshore oil and gas operations as a lack of pipeline capacity is hindering it from selling its output to regions where it can fetch a higher price.

Freeport Indonesia Unveils New Contract Terms

Related Link: 

Indonesia signed new mining contract terms with PT Freeport Indonesia, paving the way for the local unit of the U.S. mining company to resume copper concentrate exports.

Rosneft Working on Sanctions Strategy

Related Link: 

As the U.S. has imposed sanctions blocking credit to Rosneft, the Russian state-owned oil giant is looking at ways to minimize their effects.

LyondellBasell Profit Surges

Related Link: 

LyondellBasell Industries said its second-quarter earnings surged to a record level as revenue jumped.

Google's New 'Moonshot:' The Healthy Human Body

Related Link: 

Called Baseline Study, Google's project will collect anonymous genetic and molecular data to create a full picture of what a healthy human is.

Lifepoint Hospitals Profit Boosted by Health-Care Reform

Related Link: 

Lifepoint Hospitals said its second-quarter earnings jumped, leading the rural hospital operator to boost its outlook for the year amid benefits from the health-care reform law.

American Electric Posts Higher Profit

Related Link: 

American Electric Power said its second-quarter profit rose 15% as revenue increased on rate base growth and rising sales in its transmission business.

Struggling Life Insurers Look to Middle-Class

Related Link: 

MetLife and other life insurers are trying to reverse a long slide in sales of life insurance to the middle class, but it's proving a tough sell.

Syndicate content